Background Little information has been reported on regional and time trends of human
papillomavirus (HPV) prevalence rates of oropharyngeal cancer (OPC) and non‐OPC. Methods …

Refeeding syndrome is a well described but often forgotten condition. No randomised
controlled trials of treatment have been published, although there are guidelines that use best …

Background The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer,
a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal growth …

Background: We conducted a large international study to estimate fractions of head and
neck cancers (HNCs) attributable to human papillomavirus (HPV-AFs) using six HPV-related …

Background The role of image-guided surveillance as compared with planned neck dissection
in the treatment of patients with squamous-cell carcinoma of the head and neck who have …

Background. The aim of this study was to inform an evidence‐based management policy for
oral dysplastic lesions. Methods. Systematic review was performed with meta‐analysis. …

Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …

Objectives: This review examines the effectiveness of positron emission tomography (PET)
in the detection of recurrent or persistent head and neck squamous cell carcinoma after …

Context: There is controversy as to whether papillary thyroid microcarcinoma (PTMC)
represents more than one disease entity with different outcomes, requiring different treatment. …

Importance Dual blockade of programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte
associated protein 4 (CTLA-4) may overcome immune checkpoint inhibition. It is unknown …